Biotech Holds Its Own in Q2  

Oleh:

Lawrence, Stacy

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 22 no. 8 (Agu. 2004), page 938.
Topik: BIOTECHOLOGY; biotech

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.1 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

A journey market and hesitant investors befell the biotech sector in the second quarter. For financing, biotech companies are turning increasingly to debt which, excluding public investment in private equities (PIPEs), represented 27% of total funds raised. That's up significantly from the 16% it represented in the first quarter of this year (and could be due to a fall off in PIPEs). Funding from public offerings and partnership delas did hold up, but it remains to be seen if the IPO window will stay open much longer.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali